Department of Microbiology and Immunology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
J Exp Med. 2010 Mar 15;207(3):475-89. doi: 10.1084/jem.20090831. Epub 2010 Mar 8.
The function of microRNAs (miRNAs) in hematopoietic stem cells (HSCs), committed progenitors, and leukemia stem cells (LSCs) is poorly understood. We show that miR-29a is highly expressed in HSC and down-regulated in hematopoietic progenitors. Ectopic expression of miR-29a in mouse HSC/progenitors results in acquisition of self-renewal capacity by myeloid progenitors, biased myeloid differentiation, and the development of a myeloproliferative disorder that progresses to acute myeloid leukemia (AML). miR-29a promotes progenitor proliferation by expediting G1 to S/G2 cell cycle transitions. miR-29a is overexpressed in human AML and, like human LSC, miR-29a-expressing myeloid progenitors serially transplant AML. Our data indicate that miR-29a regulates early hematopoiesis and suggest that miR-29a initiates AML by converting myeloid progenitors into self-renewing LSC.
miRNAs(微小 RNA)在造血干细胞(HSCs)、定向祖细胞和白血病干细胞(LSCs)中的功能尚未完全了解。我们发现 miR-29a 在 HSC 中高度表达,在造血祖细胞中下调。miR-29a 在小鼠 HSC/祖细胞中的异位表达导致髓系祖细胞获得自我更新能力、偏向髓系分化,并发展为进展为急性髓系白血病(AML)的骨髓增生性疾病。miR-29a 通过加速 G1 到 S/G2 细胞周期转变来促进祖细胞增殖。miR-29a 在人类 AML 中过度表达,并且与人类 LSC 一样,表达 miR-29a 的髓系祖细胞可连续移植 AML。我们的数据表明 miR-29a 调节早期造血,并提示 miR-29a 通过将髓系祖细胞转化为自我更新的 LSC 引发 AML。